cancer Newsroom

Massive Bio plans acquisitions with Series B round

Massive Bio, a New York-based company with an AI tool that matches cancer patients with clinical trials appropriate to their cancer diagnosis, is planning bolt-on acquisitions following a Series B round likely to raise between USD 25m–USD 30m, co-founder and CEO Selin Kurnaz said. The health-tech company recently raised a

Groundbreaking Technology Will Increase Cancer Survival Rates Globally

CHICAGO, US, 5th June 2023 – Millions of lives will be saved thanks to a revolutionary cancer detection system, a leading UK doctor is set to reveal to global experts in Chicago today. British GP Dr Bea Bakshi will present to the American Society of Clinical Oncology (ASCO) conference

Join the 10,000+ businesses that already use PR Fire today!

Schedule a discovery call
hello@prfire.com
Join our mailing list

Linkedin Instagram Facebook Youtube

PR Fire UK PR Fire US

FAQs

Frequently Asked Questions
Newswire Services
Target Your Industry
Digital PR Solutions
How to Write an Editors Notes in a Press Release?

Policies

Cookie Policy
Terms of Use
Editorial Guidelines
PR Distribution Policy
Privacy Policy